4//SEC Filing
Faga Daniel 4
Accession 0001673528-26-000002
CIK 0001370053other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 9:07 PM ET
Size
9.3 KB
Accession
0001673528-26-000002
Insider Transaction Report
Form 4
ANAPTYSBIO, INCANAB
Faga Daniel
DirectorPresident, CEO
Transactions
- Exercise/Conversion
Common Stock
2026-01-03+34,677→ 473,448 total - Sale
Common Stock
2026-01-05$43.26/sh−15,309$662,267→ 458,139 total - Exercise/Conversion
Restricted Stock Unit
2026-01-03−34,677→ 69,355 total→ Common Stock (34,677 underlying)
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
- [F2]Reflects the acquisition of 2,305 shares acquired under the Company's ESPP.
- [F3]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F4]The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Documents
Issuer
ANAPTYSBIO, INC
CIK 0001370053
Entity typeother
Related Parties
1- filerCIK 0001673528
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 9:07 PM ET
- Size
- 9.3 KB